Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
TherapeuticsMD, Inc. (TXMD) had Income from Continuous Operations of $0.05M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.78M |
|
$0.15M |
|
-- |
|
$0.78M |
|
$1.65M |
|
$-0.86M |
|
$0.91M |
|
$0.05M |
|
$0.05M |
|
$0.05M |
|
|
Income from Continuous Operations |
$0.05M |
$0.15M |
|
$0.05M |
|
$-0.86M |
|
$-0.77M |
|
11.57M |
|
11.57M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$14.50M |
|
-- |
|
$24.17M |
|
$38.67M |
|
$4.95M |
|
-- |
|
$6.28M |
|
$11.23M |
|
$27.44M |
|
$23.53M |
|
$27.44M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$2.08M |
|
-- |
|
-- |
|
$5.06M |
|
$7.12M |
|
$2.06M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-109.95% |
|
-109.95% |
|
-- |
|
6.38% |
|
19.39% |
|
$2.08M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.21 |
|
420.73 |
|
0.18% |
|
0.21% |
|
0.13% |
|
0.18% |
|
$2.37 |
|
$0.18 |
|
$0.18 |
|